ÇALIŞKAN YILDIRIM, E. Et Al. 2023. The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.. Breast (Edinburgh, Scotland) , vol.70 , 56-62.

ÇALIŞKAN YILDIRIM, E., ATAĞ, E., Coban, E., Umit Unal, O., Celebi, A., Keser, M., ... UZUN, M.(2023). The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.. Breast (Edinburgh, Scotland) , vol.70, 56-62.

ÇALIŞKAN YILDIRIM, EDA Et Al. "The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.," Breast (Edinburgh, Scotland) , vol.70, 56-62, 2023

ÇALIŞKAN YILDIRIM, EDA Ç. Et Al. "The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.." Breast (Edinburgh, Scotland) , vol.70, pp.56-62, 2023

ÇALIŞKAN YILDIRIM, E. Et Al. (2023) . "The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.." Breast (Edinburgh, Scotland) , vol.70, pp.56-62.

@article{article, author={EDA ÇALIŞKAN YILDIRIM Et Al. }, title={The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.}, journal={Breast (Edinburgh, Scotland)}, year=2023, pages={56-62} }